Gram-negative bacteria are surrounded by a complex cell envelope that includes two 24 membranes. The outer membrane prevents many drugs from entering these cells and is thus a 25 major determinant of their intrinsic antibiotic resistance. This barrier function is imparted by the 26 asymmetric architecture of the membrane with lipopolysaccharide (LPS) in the outer leaflet 27 and phospholipids in the inner leaflet. The LPS and phospholipid synthesis pathways share a 28 common intermediate. Proper membrane biogenesis therefore requires that the flux through 29 each pathway be balanced. In Escherichia coli, a major control point in establishing this 30 balance is the committed step of LPS synthesis mediated by LpxC. Levels of this enzyme are 31 controlled through its degradation by the inner membrane protease FtsH and its presumed 32 adaptor protein LapB(YciM). How turnover of LpxC is controlled has remained unclear for 33 many years. Here, we demonstrate that the essential protein of unknown function YejM(PbgA), 34 which we have renamed ClxD (control of LpxC degradation), participates in this regulatory 35 pathway. Suppressors of ClxD essentiality were identified in lpxC and lapB, and LpxC 36 overproduction was shown to be sufficient to allow survival of ΔclxD mutants. Furthermore, the 37 half-life of LpxC was shown to be reduced in cells lacking ClxD, and genetic and physical 38 interactions between LapB and ClxD were detected. Taken together, our results are consistent 39 with a model in which ClxD directly modulates LpxC turnover by FtsH-LapB to regulate LPS 40 synthesis and maintain membrane homeostasis. 41 3 SIGNIFICANCE 43
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SIGNIFICANCE 43
The outer membrane is a major determinant of the intrinsic antibiotic resistance of Gram-44 negative bacteria. It is composed of both lipopolysaccharide (LPS) and phospholipid, and the 45 synthesis of these lipid species must be balanced for the membrane to maintain its barrier 46 function in blocking drug entry. In this report, we identify an essential protein of unknown 47 function as a key new factor in maintaining LPS/phospholipid balance in the model bacterium 48
Escherichia coli. Our results provide novel insight into how this organism and most likely other 49
Gram-negative bacteria maintain membrane homeostasis and their intrinsic resistance to 50 antibiotics. 51
INTRODUCTION 56
The bacterial cell envelope is essential for maintaining cell shape, withstanding mechanical 57 stress, resisting osmotic pressure, and is a bacterium's first line of defense against antibiotics, 58 bacteriophages, and immune cells (1, 2). In Gram-negative bacteria, the cell envelope includes 59 a symmetric inner membrane (IM) composed of phospholipids and an asymmetric outer 60 membrane (OM) consisting of phospholipids in the inner leaflet and lipopolysaccharide (LPS) 61 in the outer leaflet (2) . The cell wall is located in the periplasmic space between the IM and OM 62 and is made from a crosslinked heteropolymer called peptidoglycan (PG). Biogenesis of the 63 cell envelope is tightly coordinated with cellular growth and division (3) , with all three layers 64 having to expand and divide each cell cycle without compromising their structural integrity. 65
The phospholipid (PL) and LPS membrane components are synthesized in the cytosol and 67 within the inner leaflet of the IM. They must be transported across the IM and through the 68 periplasm to build the OM (for reviews, see (1, (4) (5) (6) ). LPS consists of three covalently attached 69 groups: a glycolipid called Lipid A, a core oligosaccharide, and a longer, variable O-antigen 70 polysaccharide chain. O-antigen is synthesized separately from the Lipid A-core, but the two 71 components are joined by ligation while anchored in the outer leaflet of the IM. Mature LPS 72 molecules are then transported from the IM to the OM by the Lpt system, which forms a protein 73 bridge connecting the IM and OM (7) . The mechanism by which PLs are transported to the OM 74 remains unclear (8) . 75 R-3-hydroxymyristoyl-Acyl Carrier Protein (ACP) serves as the acyl donor for the synthesis of 77 both PL and LPS (Fig. 1A) . In the PL synthesis pathway, it is a substrate of (3R)-78 hydroxymyristoyl-(acyl-carrier-protein) dehydratase (FabZ) (9) . It is also utilized by LpxA (UDP-79 N-acetylglucosamine acyltransferase) in the first step of Lipid A synthesis (10). However, this 80 reaction is reversible (11); the committed step for Lipid A production is catalyzed by the second 81 enzyme, UDP-3-O-acyl-N-acetylglucosamine deacetylase (LpxC) (12). Balanced synthesis of 82 LPS and PL is required to prevent loss of membrane integrity and cell death (13). In 83 Escherichia coli, this balance is in part maintained by the inner membrane-localized, ATP-84 dependent, zinc-metalloprotease FtsH (14). In conjunction with its presumed adapter protein 85 LapB(YciM) (15, 16), FtsH degrades LpxC to regulate the flux of lipid precursors through the 86 LPS pathway. However, how LpxC proteolysis is modulated in response to disruptions in LPS 87 or PL synthesis to maintain homeostasis has remained unclear for some time. 88
Here, we identify the essential membrane protein of unknown function YejM (PbgA) as an 90 inhibitor of LpxC turnover by FtsH-LapB in E. coli. We therefore have renamed the protein 91
ClxD for control of LpxC degradation. Genetic suppressors of ClxD essentiality first pointed us 92 towards its potential role in maintaining sufficient LpxC levels for LPS synthesis. Subsequent 93 analysis indicated that LpxC half-life is reduced in the absence of ClxD and that ClxD interacts 94 genetically and physically with LapB. Our results are therefore consistent with a model in which 95
ClxD interferes with LpxC proteolysis through its interaction with LapB. We propose that this 96 activity of ClxD is likely to be homeostatic and responsive to perturbations in the balance 97 between LPS and PL synthesis. 98
shares structural similarities to LtaS, the enzyme that synthesizes lipoteichoic acids in many 115
Gram-positive bacteria (21). Like LtaS, ClxD has a hydrophobic binding pocket in the 116 periplasmic domain that is important for protein function (22). However, the crystal structure of 117 this domain of ClxD revealed that it lacks residues that are important for LtaS catalytic activity, 118 indicating that is unlikely to have a similar enzymatic function (22). Although previous studies 119 have implicated ClxD in the transport of cardiolipin to the OM in Salmonella typhimurium (23) 120
and Shigella flexneri (24), a more recent study has suggested it plays a broader yet ill-defined 121 role in envelope assembly (25). We therefore thought that further study of the function of this 122 essential protein was warranted. 123
Overproduction of LpxC suppresses the essentiality of ClxD 125
To begin investigating the essential function of ClxD, we examined the terminal morphological 126 phenotype induced upon its depletion. The native clxD gene was deleted in a strain harboring 127 a plasmid that expressed clxD from an IPTG-inducible lac promoter (Plac). In the presence of 128 inducer, these cells grew and divided normally ( Fig. 1B) . However, as observed previously 129 (17, 18, 23), ClxD depletion in the absence of IPTG led to slowed growth followed by lysis of 130 the culture (Fig. 1B) . Prior to lysing, the ClxD-depleted cells formed cell chains (Fig. 1C) , 131 indicating a failure to complete cell division. This morphology is reminiscent of cells defective in 132 envelope biogenesis, including mutants defective in LPS assembly (26-28) and cells treated 133 with the LpxC inhibitor CHIR-090 (SI Appendix, Fig. S1 ). 134
We next turned to suppressor analysis to identify mutations that bypass the essentiality of 136
ClxD as a means to understand its function. To this end, the clxD gene was cloned under 137 control of the lactose promoter (Plac) in a plasmid backbone designed by the de Boer 138 laboratory to select for suppressors of ftsN essentiality (29). The vector encodes a 139 temperature-sensitive replication protein (repA ts ) and the restriction endonuclease I-SceI under 140 control of a temperature-sensitive lambda repressor (cI857), which is paired with an I-SceI cut 141 site in the vector backbone. To select for suppressors of ClxD essentiality, a ∆clxD strain 142 harboring the clxD suicide vector was plated at the non-permissive temperature (37 o C) where 143 the plasmid will cease to replicate and be cleaved by expressed I-SceI. Twelve surviving 144 colonies were isolated and their mutations were mapped by whole-genome sequencing ( Fig.  145 1A, SI Appendix, Table S1 ). Five of the suppressors contained genomic amplifications in a 146 region containing lpxC. An additional two suppressors had missense mutations in lpxC, 147
including one encoding a V37G substitution that has been demonstrated to lead to increased 148
LpxC abundance in Klebsiella pneumoniae, suggesting increased stability (30). Three of the 149 suppressors had mutations either in lapB, its neighbor lapA, or in the region upstream of the 150 lapAB operon. Overall, 10/12 suppressors had mutations predicted to increase cellular LpxC 151
levels. 152
The suppressor analysis suggested that an LpxC deficiency underpinned the lethality of a 154 ∆clxD mutation. To investigate this possibility further, lpxC was cloned under Plac control on a 155 multicopy plasmid. A strain harboring this vector was used as a recipient in a transduction 156 using P1 phage grown on a ∆clxD::Kan R donor strain. Kanamycin-resistant transductants were 157 readily obtained on agar containing IPTG to induce lpxC expression from the plasmid, and 158 these strains were found to be inducer-dependent for growth ( Fig. 1D) . Notably, the only 159 previously reported suppressor of a ∆clxD mutation was a multicopy vector encoding holo-[acyl 160
carrier protein] synthase 2 (AcpT) (17-19), and catalytic activity of the synthase was found not 161 to be required for suppression (17). Given our results, we wondered whether overproduction of 162
AcpT also acts by promoting the accumulation of LpxC. Cells overexpressing acpT from a 163 plasmid were indeed found to have elevated LpxC levels (SI Appendix, Fig. S2 ), suggesting 164 that elevated AcpT may overwhelm the FtsH proteolytic machinery and therefore allow for 165
LpxC accumulation. Taken together, our results thus far indicate that LpxC overproduction 166 renders the normally essential ClxD protein dispensable for growth. 167
LpxC is aberrantly degraded in the absence of ClxD 169
To further investigate the connection between ClxD and LpxC, we investigated the effect of 170
ClxD inactivation on the steady-state levels of LpxC. Immunoblotting indicated that LpxC levels 171 were unaffected in wildtype cells with or without moderate induction of clxD expression from a 172 plasmid ( Fig. 2A) . However, depletion of ClxD in cells deleted for the native gene led to a 173 dramatic reduction in LpxC levels to the point where it was barely detectable ( Fig. 2A) . 174
Furthermore, increased expression of clxD from a plasmid with higher concentrations of 175 inducer led to a striking increase in LpxC accumulation in otherwise wildtype cells ( Fig. 2B) . 176
Based on these results, we hypothesized that LpxC is aberrantly degraded in the absence of 177 ClxD. To test this possibility, we took advantage of our ability to delete clxD in the presence of 178 a plasmid overproducing lpxC. Wildtype and ∆clxD cells expressing lpxC from the plasmid 179 were treated with spectinomycin to block translation, and the fate of previously translated LpxC 180 was monitored by immunoblotting. In wildtype cells, the LpxC concentration decayed and then 181 plateaued at a lower steady-state level (Fig. 2C) . By contrast, LpxC levels decayed rapidly in 182 the ∆clxD cells to undetectable levels without an observable plateau. Based on these results, 183
we conclude that ClxD is required to prevent excessive turnover of LpxC. 184
ClxD interacts genetically and physically with LapB 186
Our results thus far suggested a model in which ClxD promotes LpxC accumulation by 187 protecting it from the FtsH-LapB proteolytic system. We therefore investigated whether ClxD 188 interacts with any of the components of this system using our recently developed POLAR 189 (PopZ-linked Apical Recruitment) two-hybrid assay (31). The POLAR assay takes advantage 190 of the ability of the PopZ protein from Caulobacter crescentus to spontaneously forms foci at 191 the poles of E. coli cells. Therefore, protein-protein interactions can be assessed by fusing a 192 "bait" protein a PopZ-interaction domain called H3H4 along with GFP and then monitoring 193 whether it can recruit a "prey" protein of interest fused to mScarlet to the cell pole. Using ClxD 194 as a bait, we found that it was able to recruit a LapB prey to the pole ( Fig. 3B) , but not an FtsH 195 or a LapA prey fusion ( Fig. 3C-D) . The recruitment of LapB prey to the pole was specific for 196
ClxD as it was not recruited by a transmembrane control bait (Fig. 3A) . However, we noticed 197 that cells expressing LapB-prey constructs formed chains and appeared to lyse when they 198 were paired with the control bait (SI appendix, Fig. S3 ) but not with the ClxD bait. Therefore, 199
for the control in panel 3A, we used a control bait construct in which clxD was silently 200 expressed downstream of the control bait sequence, which eliminated the adverse 201 morphological effects observed upon production of the LapB-prey fusion. We conclude that 202
ClxD interacts with the LapB component of the FtsH-LapB proteolytic system. 203
The effects of the LapB-prey fusion observed on cell growth during the POLAR analysis 205 suggested that LapB overproduction is toxic and that this toxicity can be overcome by co-206 expression clxD. To investigate this possibility further, we monitored the effect of 207 overproducing untagged LapB on cell growth when either ClxD or a GFP control was 208 simultaneously overproduced from a compatible plasmid. Cell containing the lapB expression 209 plasmid grew normally in the absence of inducer regardless of whether they overproduced 210
ClxD or GFP ( Fig. 4A) . When lapB expression was induced, plating efficiency was dramatically 211 reduced for cells producing GFP ( Fig. 4A) . However, cells co-producing ClxD were protected 212 and plated at normal efficiency ( Fig. 4A) . To investigate whether the toxicity of LapB and its 213 antagonism by ClxD was related to LpxC turnover, we monitored LpxC abundance in cells 214 overproducing LapB. Cells in which LapB and GFP were co-produced had reduced LpxC 215 levels, whereas cells overexpressing clxD had elevated levels of LpxC and no apparent 216 reduction in LpxC levels upon LapB overproduction ( Fig. 4B) . We conclude that ClxD not only 217 interacts with LapB, but that it likely serves as an antagonist of LapB activity to prevent LpxC 218 degradation by the FtsH-LapB proteolytic machinery. 219
DISCUSSION 222
The function of ClxD (YejM, PbgA) has remained unclear for some time, and it has remained 223 one of the few essential genes of unknown function in E. coli. With the exception of a multi-224 copy suppressor selection (17, 18), prior genetic studies primarily examined the phenotype of 225 mutants encoding a truncated ClxD protein lacking the non-essential C-terminal periplasmic 226 domain (17-20, 23, 25). Cells producing these ClxD-ΔC variants displayed a range of OM 227 permeability barrier defects, suggesting an important yet ill-defined role for ClxD in envelope 228
biogenesis. 229
A more specific role was assigned to the ClxD homolog from S. typhimurium, where it was 231 identified as a factor required for OM barrier function in cells activated for the two- led to the proposal that the protein functions as a transporter that shuttles CL from the IM to 239 the OM (23). In a recent follow-up study (25), mice were infected with S. typhimurium 240 producing a ClxD-ΔC variant, and following growth in the host, suppressors that restored OM 241 integrity to the ClxD-ΔC cells were isolated in lpxC, lapB, and ftsH (25). It was also found that 242 deletion of the C-terminal domain of ClxD resulted in changes in the LPS and phospholipid 243 composition of S. typhimurium that could be at least partially rescued by the suppressors(25). 244
As a result of this analysis, a variety of functions was proposed for ClxD, including a general 245 role in LPS assembly. It was also proposed that the periplasmic domain of ClxD somehow 246 facilitates lipid trafficking during stress and that the transmembrane region performs an 247 undefined essential activity involving phospholipids (25). 248
A simplified picture of ClxD function emerges from our study of a complete deletion allele of 250 clxD in E. coli. Similar to the host-induced suppressors of the S. typhimurium ClxD-ΔC defect, 251
we identified suppressors of ClxD essentiality in the lpxC and lapB genes. We further showed 252 that overexpression of lpxC was sufficient to allow complete deletion of clxD. Subsequent 253 analysis demonstrated that levels of LpxC were strongly dependent on ClxD. Inactivation of 254
ClxD led to increased degradation of LpxC and reduced levels of the enzyme, whereas 255 overproduction of ClxD promoted the hyper-accumulation of LpxC. We then identified an 256 interaction between ClxD and LapB and discovered that ClxD prevents excessive LpxC 257 degradation upon LapB overproduction. Overall, our results are consistent with a model in 258
which ClxD opposes LapB function to inhibit LpxC degradation by the FtsH protease ( Fig. 5) . 259 We therefore suspect that most of the OM defects observed previously for cells producing 260
ClxD-ΔC variants ultimately stem from perturbations to LpxC levels and that a lipid transport 261 function for the protein is unlikely. 262
The ability of ClxD to antagonize LpxC degradation makes it an attractive candidate for a factor 264 that modulates the stability of LpxC in response to disruptions in LPS and phospholipid 265 synthesis homeostasis. It has been known for some time that inhibition of LpxC or 266 overexpression of fabZ, both of which presumably shift flux of lipid precursors away from the 267 LPS synthesis pathway, leads to the stabilization of LpxC (9, 30, 34, 35) . Recently, it has also 268 been shown that LpxC turnover is reduced in cells with elevated activity of phospholipase A 269 (PldA), which cleaves phospholipids in the outer leaflet of the OM, another marker for defects 270 in LPS and phospholipid synthesis homeostasis (36). In each of these cases, the precise 271 molecular signal(s) that modulate LpxC degradation by FtsH-LapB remains to be determined. 272
However, lipids like acyl-CoA, LPS, phospholipids, or intermediates in the synthesis of these 273 molecules are likely candidates (34, 36). Notably, ClxD is related to enzymes like LtaS and 274
EptA that use phospholipid substrates to either polymerize lipoteichoic acids or to modify Lipid 275 A with a lipid head-group, respectively. Even though ClxD lacks amino acids predicted to be 276 required for enzymatic activity, it is conceivable that it retains the ability to bind LPS, 277 phospholipids, or both, and that such binding events modulate its ability to interfere with LpxC 278 degradation by FtsH-LapB. Although further studies are required to test these possibilities, the 279 identification of ClxD as an essential component in the pathway controlling LpxC levels 280
represents an important step towards a mechanistic understanding of how gram-negative 281 bacteria balance phospholipid and LPS synthesis to properly assemble to OM layer that 282 defines them. 283
METHODS AND MATERIALS 287

Bacterial Strains and Growth Conditions 289
All strains used and generated here are derivatives of MG1655. Strains were cultured in LB 290 media (1% tryptone, 0.5% yeast extract, 0.5% NaCl) or minimal M9 media (37) supplemented 291 with 0.2% casamino acids and 0.2% glucose, arabinose, or maltose as indicated. were maintained on medium supplemented with 50 µM IPTG unless otherwise stated. All 296 strains, plasmids, and primers used in this study are listed in SI Appendix Table S2 , SI 297
Appendix Table S3 , and SI Appendix Table S4 , respectively. Methods used to construct the 298 ∆clxD strains and expression constructs used in this study are detailed in the SI Appendix. 299
Selection of suppressors of ClxD essentiality 301
The suppressor strain plasmid (pEMF20) was cloned via Gibson assembly in strain JLB45, 302 which expresses cI857, in order to prevent zygotic induction of I-SceI. The plasmid was then 303 transformed into MG1655 Chung competent cells. The ∆clxD::kan R allele was transduced into 304 MG1655/pEMF20 via P1 transduction and confirmed via PCR (see above) generating strain 305 EMF37. Suppressors of ∆clxD were selected by growing EMF37 cells at 37˚C on LB plates 306 (including 1% SDS, as indicated). An overnight culture of EMF37 was prepared at the 307 permissive condition (30˚C, LB + Kan + Spec +100 µM IPTG). For suppressors EMF40-44, the 308 EMF37 overnight culture was serially diluted and plated on LB plates and incubated at 37˚C. 309
For suppressors EMF45-51, the overnight culture of EMF37 was back diluted 1:50 and grown 310 under permissive conditions until OD600 = 0.42. Cells were then pelleted, washed, and 311 resuspended in LB and allowed to grow for an additional hour at 37˚C (non-permissive 312 conditions). Cells were then plated on LB and incubated overnight at 37˚C. The loss of plasmid 313 pEMF20 was confirmed by screening for spectinomycin sensitivity. Overnight cultures of the 314 suppressor strains were prepared, and 5 ml of each culture was pelleted and stored at -20˚C. 315 gDNA was isolated from each pellet using the Wizard Genomic DNA Purification Kit (Promega) 316 and further purified using the Genomic DNA Clean & Concentrate kit (Zymo Research). Whole 317 genome sequencing was performed as described previously (38) with some modifications (39) 318 (Nextera DNA Sample Preparation kit). The concentration of the DNA in the samples was 319 determined using the Qubit dsDNA HS Assay Kit and the sizes of the products following 320 tagmentation were determined using a High Sensitivity D1000 screen tape run on an Agilent 321 4200 TapeStation. The sequencing was carried out using a MiSeq Reagent Kit v3 (Illumina). 322
The data was analyzed using the CLC Genomics Workbench software (Qiagen). 323
Immunoblotting 325
Cell pellets were collected and resuspended in water and 2x Laemmli sample buffer [100 mM 326
Tris-HCL, pH 6.8; 2% SDS, 0.1% Bromophenol Blue, 20% glycerol] at a 1:1 ratio. Samples 327 were boiled for 10 minutes and sonicated (Qsonica Tip Sonicator-Amp: 25%, Time: 1 min) 2-3 328 times. Protein concentration was measuring using the NI (Non-interfering) Protein Assay (With 329 BSA Protein Standard)(G Biosciences cat #786-005) and was normalized using 1x sample 330 buffer. Samples were run on a 15% polyacrylamide gel and transferred to a PVDF membrane. 331
The membrane was then rinsed in Phosphate-Buffered Saline + 0.1% tween (PBS-T) [10% 332
10x PBS buffer PBS-T, pH 7.4(Sigma Aldrich); 0.1% Tween 20) and blocked in 5% milk in 333 PBS-T for 1.5 hrs. The membrane was then incubated in primary antibody solution of 1% milk 334 in PBS-T + rabbit anti-lpxC antibody (generous gift from the Doerrler lab) at a 1:10,000 dilution 335 for approximately 16 hours at 4˚C. The membrane was then washed 4x in PBS-T (1x quickly, 336 3x for 10 min per wash). The membrane was then incubated in secondary antibody solution 337 (anti-rabbit IgG HRP, 1:1000 dilution, Rockland 18-8816-33) in 0.2% milk in PBS-T for 2 hrs. 338 were grown for 90 minutes and fixed before being visualized by phase contrast microscopy. 370
Phase Contrast Microscopy 372
For the phase contrast micrographs in Fig. 1 and SI Appendix Fig. S1 , cells were fixed in 373 2.6% in formaldehyde and 0.04% glutaraldehyde at room temperature for 1 hr and stored at 374 4˚C for up to three days. Prior to imaging, samples were immobilized on 2% agarose pads on 375 1 mm glass slides and # 1.5 coverslips were used. Samples were imaged on a Nikon TE2000 376 inverted microscope using Nikon Elements Acquisition Software AR 3.2. Cropping and 377 additional adjustments were made using FIJI software. 378
POLAR analysis 380
Cells were prepared for imaging as described previously (31). Briefly, cells from a single 381 colony were grown in LB media supplemented with Tet and Cam for 2 hours at 37˚C. Cells 382 were back-diluted in M9 + 0.2% arabinose and 100 µM IPTG and incubated for 2 hours at 383 37˚C to induce expression of bait and prey protein fusions. Cells were immobilized on agarose 384 pads as above for imaging. Micrographs were taken on a Nikon Ti Inverted Microscope with a 385 Plan Apo lambda 100x/1.45 Oil Ph3 DM objective lens , Lumencore SpectraX LED 386 Illumination, Chroma ET Filter Cubes GFP (49002) and mCherry (49008), a Andor Zyla 4.2 387
Plus sCMOS Camera, and Nikon Elements 4.30 acquisition software. The microscope slide 388 was kept at 30˚C using an environmental control chamber. Demographs showing polar 389 localization were generated using a custom MATLAB code as described previously (31). Cells 390 were aligned by length and oriented so that the pole with greater bait intensity is located on the 391 right. The corresponding demograph of the prey signal was generated using the same 392 orientation. 393
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Figure 1. The depletion of ClxD leads to cell chaining and lysis. A.
Shown is the branched synthesis pathway leading from R-3-hydroxymyistoyl-ACP to either phospholipid or LPS. LpxC is turned over by FtsH. LapB is thought to serve as an adapter in the process. LapA is also shown, but its role in LpxC degradation is not clear. The identity of variants that suppress ClxD essentiality are indicated in the diagram. B. Growth curve following the depletion of ClxD. Cells of strain EMF27 [∆clxD/Plac::clxD] were grown without (red) or with (black) 50 µM IPTG to induce clxD expression and growth was monitored by following culture OD600. C. Micrographs of cells at the 125 minute time point of the growth curve shown in B. Scale bar = 5 µm D. Serial dilutions of wildtype and ∆clxD cells harboring a Plac::lpxC plasmid were plated in the absence and presence of 50 µM IPTG as indicated. (lanes 1 and 3) or presence (lanes 2 and 4) of 1 mM IPTG. Note that the clxD in this plasmid has a strong artificial ribosome-binding site relative to the construct used in A.C. Wildtype and ∆clxD cells harboring a Plac::lpxC plasmid (pPR111) were grown in the presence of 50 µM IPTG at 30˚C in minimal medium to an OD600 of 0.5. Spectinomycin (300 µg/mL) was then added, and samples were taken at the indicated time points for the preparation of extracts and the detection of LpxC by immunoblotting. The (*) denotes a nonspecific band that appeared sporadically in blots of the ∆clxD samples. Blots shown are representative of three independent experiments. for lack of growth in the absence of inducer. The ∆clxD::kan R allele was then transduced from EMF25 into TB28/pEMF17 to generate strain EMF27. The genotype was confirmed by PCR and lack of growth in the absence of inducer.
MATERIALS AND METHODS
Construction
Construction of the ∆clxD strain EMF30 [∆clxD::kan R /Plac::lpxC]
The ∆clxD::kan R allele was transduced into MG1655/pPR111 [WT/Plac::lpxC].
Transductants were selected on LB + Cam + Kan + 50 µM IPTG. The transduction was confirmed via PCR (see above).
